152 related articles for article (PubMed ID: 28357490)
21. FOXF1 as an Immunohistochemical Marker of Hilar Cholangiocarcinoma or Metastatic Pancreatic Ductal Adenocarcinoma. Single Institution Experience.
Hrudka J; Prouzová Z; Mydlíková K; Jedličková K; Holešta M; Whitley A; Havlůj L
Pathol Oncol Res; 2021; 27():1609756. PubMed ID: 34257615
[TBL] [Abstract][Full Text] [Related]
22. Diagnostic value of immunohistochemical IMP3 expression in core needle biopsies of pancreatic ductal adenocarcinoma.
Wachter DL; Schlabrakowski A; Hoegel J; Kristiansen G; Hartmann A; Riener MO
Am J Surg Pathol; 2011 Jun; 35(6):873-7. PubMed ID: 21566520
[TBL] [Abstract][Full Text] [Related]
23. C-Reactive Protein (CRP) is a Promising Diagnostic Immunohistochemical Marker for Intrahepatic Cholangiocarcinoma and is Associated With Better Prognosis.
Yeh YC; Lei HJ; Chen MH; Ho HL; Chiu LY; Li CP; Wang YC
Am J Surg Pathol; 2017 Dec; 41(12):1630-1641. PubMed ID: 28945626
[TBL] [Abstract][Full Text] [Related]
24. Association of annexin A10 expression with poor prognosis of intrahepatic cholangiocarcinoma.
Shao YY; Kuo HY; Jeng YM; Wu YM; Wang HP; Hsu C; Hsu CH; Hsu HC; Cheng AL; Lin ZZ
BMC Cancer; 2022 Feb; 22(1):219. PubMed ID: 35227227
[TBL] [Abstract][Full Text] [Related]
25. Utility of KRAS mutational analysis in the preoperative diagnosis of synchronous pancreatic cancer and intrahepatic cholangiocarcinoma: A case report.
Eso Y; Uza N; Yamagishi H; Imada K; Kimura Y; Masui T; Kodama Y; Seno H
Medicine (Baltimore); 2017 Dec; 96(50):e9217. PubMed ID: 29390348
[TBL] [Abstract][Full Text] [Related]
26. Thrombospondin-2 as a diagnostic biomarker for distal cholangiocarcinoma and pancreatic ductal adenocarcinoma.
Byrling J; Hilmersson KS; Ansari D; Andersson R; Andersson B
Clin Transl Oncol; 2022 Feb; 24(2):297-304. PubMed ID: 34319497
[TBL] [Abstract][Full Text] [Related]
27. Combined Expression of Plasma Thrombospondin-2 and CA19-9 for Diagnosis of Pancreatic Cancer and Distal Cholangiocarcinoma: A Proteome Approach.
Le Large TYS; Meijer LL; Paleckyte R; Boyd LNC; Kok B; Wurdinger T; Schelfhorst T; Piersma SR; Pham TV; van Grieken NCT; Zonderhuis BM; Daams F; van Laarhoven HWM; Bijlsma MF; Jimenez CR; Giovannetti E; Kazemier G
Oncologist; 2020 Apr; 25(4):e634-e643. PubMed ID: 31943574
[TBL] [Abstract][Full Text] [Related]
28. Semiquantitative immunohistochemistry for mucin (MUC1, MUC2, MUC3, MUC4, MUC5AC, and MUC6) profiling of pancreatic ductal cell adenocarcinoma improves diagnostic and prognostic performance.
Sierzega M; Młynarski D; Tomaszewska R; Kulig J
Histopathology; 2016 Oct; 69(4):582-91. PubMed ID: 27165582
[TBL] [Abstract][Full Text] [Related]
29. Urinary Metabolites Diagnostic and Prognostic of Intrahepatic Cholangiocarcinoma.
Haznadar M; Diehl CM; Parker AL; Krausz KW; Bowman ED; Rabibhadana S; Forgues M; Bhudhisawasdi V; Gonzalez FJ; Mahidol C; Budhu A; Wang XW; Ruchirawat M; Harris CC
Cancer Epidemiol Biomarkers Prev; 2019 Oct; 28(10):1704-1711. PubMed ID: 31358519
[TBL] [Abstract][Full Text] [Related]
30. A differential microRNA profile distinguishes cholangiocarcinoma from pancreatic adenocarcinoma.
Collins AL; Wojcik S; Liu J; Frankel WL; Alder H; Yu L; Schmittgen TD; Croce CM; Bloomston M
Ann Surg Oncol; 2014 Jan; 21(1):133-8. PubMed ID: 24046106
[TBL] [Abstract][Full Text] [Related]
31. Utility of immunohistochemistry in the pancreatobiliary tract.
Lin F; Chen ZE; Wang HL
Arch Pathol Lab Med; 2015 Jan; 139(1):24-38. PubMed ID: 25549142
[TBL] [Abstract][Full Text] [Related]
32. The Ability to Diagnose Intrahepatic Cholangiocarcinoma Definitively Using Novel Branched DNA-Enhanced Albumin RNA In Situ Hybridization Technology.
Ferrone CR; Ting DT; Shahid M; Konstantinidis IT; Sabbatino F; Goyal L; Rice-Stitt T; Mubeen A; Arora K; Bardeesey N; Miura J; Gamblin TC; Zhu AX; Borger D; Lillemoe KD; Rivera MN; Deshpande V
Ann Surg Oncol; 2016 Jan; 23(1):290-6. PubMed ID: 25519926
[TBL] [Abstract][Full Text] [Related]
33. Inflammatory cytokines and combined biomarker panels in pancreatic ductal adenocarcinoma: Enhancing diagnostic accuracy.
Kruger D; Yako YY; Devar J; Lahoud N; Smith M
PLoS One; 2019; 14(8):e0221169. PubMed ID: 31415645
[TBL] [Abstract][Full Text] [Related]
34. Small pancreatic carcinoma misdiagnosed as superficially spreading cholangiocarcinoma.
Igami T; Yokoyama Y; Nishio H; Ebata T; Shimoyama Y; Nakamura S; Nagino M
J Hepatobiliary Pancreat Surg; 2009; 16(4):579-84. PubMed ID: 19259611
[TBL] [Abstract][Full Text] [Related]
35. The significance of galectin-3 immunohistochemistry, clinical characteristics and liver imaging in differentiating intrahepatic cholangiocarcinoma from adenocarcinoma liver metastasis.
Dechaphunkul A; Kanngurn S; Dechsukhum C; Tanutit P; Khow-Ean U; Sunpaweravong P
J Med Assoc Thai; 2010 May; 93(5):523-8. PubMed ID: 20524437
[TBL] [Abstract][Full Text] [Related]
36. Review and Application of Integrin Alpha v Beta 6 in the Diagnosis and Treatment of Cholangiocarcinoma and Pancreatic Ductal Adenocarcinoma.
Lian Y; Zeng S; Wen S; Zhao X; Fang C; Zeng N
Technol Cancer Res Treat; 2023; 22():15330338231189399. PubMed ID: 37525872
[TBL] [Abstract][Full Text] [Related]
37. Gene expression profiling of serrated polyps identifies annexin A10 as a marker of a sessile serrated adenoma/polyp.
Gonzalo DH; Lai KK; Shadrach B; Goldblum JR; Bennett AE; Downs-Kelly E; Liu X; Henricks W; Patil DT; Carver P; Na J; Gopalan B; Rybicki L; Pai RK
J Pathol; 2013 Aug; 230(4):420-9. PubMed ID: 23595865
[TBL] [Abstract][Full Text] [Related]
38. Molecular and cytogenomic profiling of hepatic adenocarcinoma expressing inhibinA, a mimicker of neuroendocrine tumors: proposal to reclassify as "cholangioblastic variant of intrahepatic cholangiocarcinoma".
Braxton DR; Saxe D; Damjanov N; Stashek K; Shroff S; Morrissette JD; Tondon R; Furth EE
Hum Pathol; 2017 Apr; 62():232-241. PubMed ID: 28232156
[TBL] [Abstract][Full Text] [Related]
39. Roles of serum and biliary CEA, CA19-9, VEGFR3, and TAC in differentiating between malignant and benign biliary obstructions.
Ince AT; Yıldız K; Baysal B; Danalıoğlu A; Kocaman O; Tozlu M; Gangarapu V; Sarbay Kemik A; Uysal Ö; Şentürk H
Turk J Gastroenterol; 2014 Apr; 25(2):162-9. PubMed ID: 25003676
[TBL] [Abstract][Full Text] [Related]
40. The diagnostic efficacy of CYFRA21-1 on intrahepatic cholangiocarcinoma: A meta-analysis.
Guowei H; Yuan L; Ma L; Zhongyang L; Zhixing S; Lin L; Minqi L
Clin Res Hepatol Gastroenterol; 2019 Jun; 43(3):266-272. PubMed ID: 30503663
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
